What is it about?

Advanced prostate cancer that has spread to the bone is a significant clinical problem. We have developed a bone targeted nanoparticle system that allows for improved delivery of chemotherapy to where the cancer has spread.

Featured Image

Read the Original

This page is a summary of: Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain, Nanomedicine, September 2017, Future Medicine,
DOI: 10.2217/nnm-2017-0190.
You can read the full text:

Read

Contributors

The following have contributed to this page